Evidence map›Paper›PMID 39734222›Full record

ArticleMicrobiome2024

Live Akkermansia muciniphila boosts dendritic cell retinoic acid synthesis to modulate IL-22 activity and mitigate colitis in mice.

Hongbin Liu, Ruo Huang, Binhai Shen, Chongyang Huang, Qian Zhou, Jiahui Xu, Shengbo Chen, Xinlong Lin, Jun Wang, Xinmei Zhao and 6 more

Erratum issuedAbstract read
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Unveiling the Molecular Repertoire ofJournal of microbiology and biotechnology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Microorganisms · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Strain-dependent efficacy of pasteurizedFrontiers in nutrition · 2026
    Article
  17. Review
  18. Article
  19. Frontiers in immunology · 2026
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Hongbin Liu *Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ruo Huang *Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Binhai Shen *Department of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chongyang HuangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Qian ZhouDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jiahui XuDepartment of Gastroenterology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Shengbo ChenDepartment of Gastroenterology, Institute of Digestive Diseases, The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, China.
Xinlong LinDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jun WangDepartment of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Xinmei ZhaoDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yandong GuoDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiuyun AiHuiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yangyang LiuGuangzhou ZhiYi Biotechnology Co., Ltd, Guangzhou, China.
Ye WangGuangzhou ZhiYi Biotechnology Co., Ltd, Guangzhou, China.
Wendi ZhangDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. zhang_wendi@163.com.
Fachao ZhiDepartment of Gastroenterology, Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Nanfang Hospital, Southern Medical University, Guangzhou, China. zhifc41532@163.com.

Funding

China Postdoctoral Science Foundation 2022M721510National Natural Science Foundation of China 81970465National Natural Science Foundation of China 82373282Science and Technology Planning Project of Guangdong Province 2017B020209003Science and Technology Planning Project of Guangdong Province 2022A1515012649
6 · The paper itself

Abstract

backgroundThe interplay between gut microbiota and immune responses is crucial in ulcerative colitis (UC). Though Akkermansia muciniphila (Akk) shows therapeutic potential, the mechanisms remain unclear. This study sought to investigate differences in therapeutic efficacy among different forms or strains of Akk and elucidate the underlying mechanisms.

resultsEmploying a dextran sulfate sodium (DSS)-induced colitis mouse model, we assessed Akk's impact on colitis using cellular cytokine analysis, immune phenotyping, proteomics, and biochemical methods. Our results suggest that treatment with live Akk effectively reduced colitis in the DSS-induced model, whereas heat-inactivated Akk did not yield the same results. Notably, Akk exhibited protective properties by promoting the secretion of IL-22 by Group 3 innate lymphoid cells (ILC3s), as evidenced by the absence of protection in IL-22 knockout mice. Additionally, Akk augmented the population of CD103

conclusionsIn summary, our findings indicate that certain strains of Akk may mitigate colitis through the promotion of RA synthesis and IL-22 secretion, underscoring the potential efficacy of Akk as a therapeutic intervention for the management of UC. Video Abstract.

Indexed as

AkkermansiaDendritic CellsDisease Models, AnimalInterleukin-22InterleukinsMice, KnockoutTretinoinAnimalsColitisColitis, UlcerativeDextran SulfateGastrointestinal MicrobiomeMiceMice, Inbred C57BLProbioticsDextran SulfateInterleukin-22InterleukinsTretinoinAkkermansia muciniphilaDendritic cellsGroup 3 innate lymphoid cellsIL-22Retinoic acidSTAT3Ulcerative colitis

Identifiers

PMID39734222
PMCPMC11684322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.